David B. Bharucha

847 total citations
30 papers, 499 citations indexed

About

David B. Bharucha is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, David B. Bharucha has authored 30 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in David B. Bharucha's work include Cardiac Arrhythmias and Treatments (16 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Cardiac electrophysiology and arrhythmias (13 papers). David B. Bharucha is often cited by papers focused on Cardiac Arrhythmias and Treatments (16 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Cardiac electrophysiology and arrhythmias (13 papers). David B. Bharucha collaborates with scholars based in United States, Canada and United Kingdom. David B. Bharucha's co-authors include Peter R. Kowey, Roger A. Marinchak, Seth J. Rials, G. Michael Felker, Marco Metra, John R. Teerlink, Justin A. Ezekowitz, David G. Soergel, Gerasimos Filippatos and Gad Cotter and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

David B. Bharucha

25 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David B. Bharucha United States	12	297	192	66	63	46	30	499
Christopher Doe United States	14	220 0.7×	199 1.0×	25 0.4×	72 1.1×	57 1.2×	21	579
Y. G. Yap United Kingdom	7	685 2.3×	363 1.9×	63 1.0×	10 0.2×	31 0.7×	11	914
Anusak Kijtawornrat Thailand	13	339 1.1×	235 1.2×	22 0.3×	19 0.3×	29 0.6×	75	628
Jacob Rune Jørgensen Denmark	8	212 0.7×	188 1.0×	65 1.0×	137 2.2×	8 0.2×	13	591
Gabriella Baldi Italy	13	181 0.6×	134 0.7×	41 0.6×	131 2.1×	45 1.0×	27	578
Tetsuya Kitayama Japan	10	195 0.7×	159 0.8×	45 0.7×	89 1.4×	7 0.2×	17	342
Kazuhito Shiosakai Japan	15	151 0.5×	81 0.4×	13 0.2×	133 2.1×	88 1.9×	58	544
Kazuya Fukumura Japan	14	237 0.8×	61 0.3×	31 0.5×	12 0.2×	16 0.3×	30	709
Maria Sunzel Sweden	11	158 0.5×	69 0.4×	31 0.5×	89 1.4×	9 0.2×	17	425
Surai Thaneemit-Chen United States	7	397 1.3×	257 1.3×	30 0.5×	112 1.8×	6 0.1×	7	557

Countries citing papers authored by David B. Bharucha

Since Specialization

Citations

This map shows the geographic impact of David B. Bharucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Bharucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Bharucha more than expected).

Fields of papers citing papers by David B. Bharucha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Bharucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Bharucha. The network helps show where David B. Bharucha may publish in the future.

Co-authorship network of co-authors of David B. Bharucha

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Bharucha. A scholar is included among the top collaborators of David B. Bharucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Bharucha. David B. Bharucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desai, Nihar R., Craig Evan Pollack, Naomi Sacks, et al.. (2025). 391 Emergency Department Visits for PSVT: An Analysis of the HCUP Nationwide Emergency Department Sample. Annals of Emergency Medicine. 86(3). S169–S170.

Coutu, Benoit, James E. Ip, Peter A. Noseworthy, et al.. (2025). Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study. Journal of Cardiovascular Electrophysiology. 36(11). 2990–3003.

Ip, James E., My Bui, A. John Camm, et al.. (2024). Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings. American Heart Journal. 270. 55–61. 1 indexed citations

Stambler, Bruce S., Marco Alings, Paul Dorian, et al.. (2024). CE-482905-001 SELF-ADMINISTERED ETRIPAMIL NASAL SPRAY RAPIDLY TERMINATED SPONTANEOUS PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT): ANALYSIS OF OPEN-LABEL TREATMENT IN THE RAPID STUDY. Heart Rhythm. 21(5). S32–S32.

Camm, A. John, James E. Ip, Benoit Coutu, et al.. (2024). Quality of life measures with etripamil self-administration for acute episodes of paroxysmal supraventricular tachycardia in a medically unsupervised setting: patient-reported outcomes from NODE-303. European Heart Journal. 45(Supplement_1).

Dorian, Paul, Benoit Coutu, James E. Ip, et al.. (2023). MP-453091-1 EFFECT OF ETRIPAMIL NASAL SPRAY ON VENTRICULAR RATE IN PATIENTS EXPERIENCING SYMPTOMATIC ATRIAL FIBRILLATION. Heart Rhythm. 20(5). S109–S109. 1 indexed citations

Camm, A. John, Jonathan P. Piccini, Marco Alings, et al.. (2023). Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201). Circulation Arrhythmia and Electrophysiology. 16(12). 639–650. 5 indexed citations

Pokorney, Sean D., A. John Camm, Paul Dorian, et al.. (2023). CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia. Value in Health. 26(6). S41–S41. 2 indexed citations

Piccini, Jonathan P., Anders Ahlsson, Paul Dorian, et al.. (2021). Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study. American Heart Journal. 245. 51–59. 12 indexed citations

10.

Cotter, Gad, Beth A. Davison, Javed Butler, et al.. (2017). Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF. Clinical Research in Cardiology. 107(2). 170–181. 33 indexed citations

11.

Pang, Peter S., Javed Butler, Sean P. Collins, et al.. (2017). Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). European Heart Journal. 38(30). 2364–2373. 107 indexed citations

12.

Weber, Michael A., et al.. (2016). The Effects of Nebivolol-Valsartan Single-Pill Combinations in Reducing Blood Pressure in Patients with Stage I or II Hypertension. Journal of the American Society of Hypertension. 10. e8–e8. 2 indexed citations

13.

Robinson, Victoria M., David B. Bharucha, Kenneth W. Mahaffey, Paul Dorian, & Peter R. Kowey. (2016). Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial. American Heart Journal. 185. 43–51. 10 indexed citations

14.

Warach, Steven, Yasir Al‐Rawi, Anthony J. Furlan, et al.. (2012). Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection. Stroke. 43(9). 2313–2318. 44 indexed citations

15.

Kowey, Peter R., Roger A. Marinchak, Seth J. Rials, & David B. Bharucha. (2000). Classification and pharmacology of antiarrhythmic drugs. American Heart Journal. 140(1). 12–20. 26 indexed citations

16.

Bharucha, David B. & Peter R. Kowey. (2000). Management and prevention of atrial fibrillation after cardiovascular surgery. The American Journal of Cardiology. 85(10). 20–24. 32 indexed citations

17.

Kowey, Peter R., Roger A. Marinchak, Seth J. Rials, & David B. Bharucha. (1999). Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation. The American Journal of Cardiology. 84(9). 46–51. 8 indexed citations

18.

Kowey, Peter R., Roger A. Marinchak, Seth J. Rials, Susan Heaney, & David B. Bharucha. (1998). Atrial fibrillation trials: will they teach us what we need to know?. The American Journal of Cardiology. 82(7). 86N–91N. 9 indexed citations

19.

Kowey, Peter R., Roger A. Marinchak, Seth J. Rials, & David B. Bharucha. (1997). Pharmacologic and Pharmacokinetic Profile of Class III Antiarrhythmic Drugs. The American Journal of Cardiology. 80(8). 16G–23G. 25 indexed citations

20.

Holmes, Niall, et al.. (1984). Comparison of the primary structures of clathrin light chains from bovine brain and adrenal gland by peptide mapping.. The EMBO Journal. 3(7). 1621–1627. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact